Abstract
Gynaecological cancer patients who present with an isolated recurrence after having undergone definitive radiation treatment pose a therapeutic dilemma, balancing risks of retreatment with a desire to optimise local control. A patient’s suitability for a radical approach to retreatment is determined by multiple factors: their clinical performance status and symptomatology, previous radiotherapy and radiation-related toxicities and disease extent. Ever improving technologies have changed the goalposts for treatment, and an aggressive approach is worth pursuing in carefully selected patients, where not only palliation of local symptoms is possible but also long-term local control can be a realistic aim. In this review, clinical, tumour and radiobiological factors as well as technological features have been formulated into a treatment algorithm for the patient presenting for consideration of re-irradiation for recurrent gynaecological malignancy.
M. Morgia and L. Walsh contributed equally to this work.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Aalders JG, Abeler V, Kolstad P (1984) Recurrent adenocarcinoma of the endometrium: a clinical and histopathological study of 379 patients. Gynecol Oncol 17:85–103
Andreu-Martinez FJ, Martinez-Mateu JM (2005) Hypoxia and anaemia in patients with cancer of the uterine cervix. Clin Transl Oncol 7:323–331
Andreyev J (2005) Gastrointestinal complications of pelvic radiotherapy: are they of any importance? Gut 54:1051–1054
Anthopoulos AP, Manetta A, Larson JE et al (1989) Pelvic exenteration: a morbidity and mortality analysis of a seven-year experience. Gynecol Oncol 35:219–223
Badakh DK, Grover AH (2009) Reirradiation with high-dose-rate remote afterloading brachytherapy implant in patients with locally recurrent or residual cervical carcinoma. J Cancer Res Ther 5:24–30
Bauer M, Schulz-Wendtland R (1989) The radiobiology of gynecologic HDR and LDR afterloading technics. Rontgenblatter 42:54–56
Bourhis J, Overgaard J, Audry H et al (2006) Hyperfractionated or accelerated radiotherapy in head and neck cancer: a meta-analysis. Lancet 368:843–854
Brabham JG, Cardenes HR (2009) Permanent interstitial reirradiation with 198Au as salvage therapy for low volume recurrent gynecologic malignancies: a single institution experience. Am J Clin Oncol 32:417–422
Denton AS, Bond SJ, Matthews S et al (2000) National audit of the management and outcome of carcinoma of the cervix treated with radiotherapy in 1993. Clin Oncol (R Coll Radiol) 12:347–353
Deodato F, Macchia G, Grimaldi L et al (2009) Stereotactic radiotherapy in recurrent gynecological cancer: a case series. Oncol Rep 22:415–419
Eifel PJ, Levenback C, Wharton JT et al (1995) Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 32:1289–1300
Fotopoulou C, Neumann U, Kraetschell R et al (2010) Long-term clinical outcome of pelvic exenteration in patients with advanced gynecological malignancies. J Surg Oncol 101:507–512
Fowler JF, Van Limbergen EF (1997) Biological effect of pulsed dose rate brachytherapy with stepping sources if short half-times of repair are present in tissues. Int J Radiat Oncol Biol Phys 37:877–883
Fuller AF Jr, Elliott N, Kosloff C et al (1989) Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix. Gynecol Oncol 33:34–39
Georg P, Kirisits C, Goldner G et al (2009) Correlation of dose-volume parameters, endoscopic and clinical rectal side effects in cervix cancer patients treated with definitive radiotherapy including MRI-based brachytherapy. Radiother Oncol 91:173–180
Guckenberger M, Bachmann J, Wulf J et al (2010) Stereotactic body radiotherapy for local boost irradiation in unfavourable locally recurrent gynaecological cancer. Radiother Oncol 94:53–59
Gupta AK, Vicini FA, Frazier AJ et al (1999) Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies. Int J Radiat Oncol Biol Phys 43:1055-1060
Hasselle MD, Rose BS, Kochanski JD et al (2010) Clinical outcomes of intensity-modulated pelvic radiation therapy for carcinoma of the cervix. Int J Radiat Oncol Biol Phys. In press
Hauspy J, Beiner ME, Harley I et al (2010) Role of adjuvant radiotherapy in granulosa cell tumors of the ovary. Int J Radiat Oncol Biol Phys. In press
Hockel M, Sclenger K, Hamm H et al (1996) Five-year experience with combined operative and radiotherapeutic treatment of recurrent gynecologic tumors infiltrating the pelvic wall. Cancer 77:1918–1933
Jones B, Blake PR (1999) Retreatment of cancer after radical radiotherapy. Br J Radiol 72:1037–1039
Jhingran A, Burke TW, Eifel PJ (2003) Definitive radiotherapy for patients with isolated vaginal recurrence of endometrial carcinoma after hysterectomy. Int J Radiat Oncol Biol Phys 56:1366-1372
Jones TK Jr, Levitt SH, King ER (1970) Retreatment of persistent and recurrent carcinoma of the cervix with irradiation. Radiology 95:167–174
Joseph KJ, Al-Mandhari Z, Pervez N et al (2008) Reirradiation after radical radiation therapy: a survey of patterns of practice among Canadian radiation oncologists. Int J Radiat Oncol Biol Phys 72:1523–1529
Kapp KS, Stuecklschweiger GF, Kapp DS et al (1997) Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy. Radiother Oncol 42:143–153
Kirisits C, Potter R, Lang S et al (2005) Dose and volume parameters for MRI-based treatment planning in intracavitary brachytherapy for cervical cancer. Int J Radiat Oncol Biol Phys 62:901–911
Kunos C, Chen W, DeBernardo R et al (2009) Stereotactic body radiosurgery for pelvic relapse of gynecologic malignancies. Technol Cancer Res Treat 8:393–400
Look KY, Rocereto TF (1990) Relapse patterns in FIGO stage IB carcinoma of the cervix. Gynecol Oncol 38:114–120
Maggioni A, Roviglione G, Landoni F et al (2009) Pelvic exenteration: ten-year experience at the European Institute of Oncology in Milan. Gynecol Oncol 114:64–68
Mahe MA, Gerard JP, Dubois JB et al (1996) Intraoperative radiation therapy in recurrent carcinoma of the uterine cervix: report of the French intraoperative group on 70 patients. Int J Radiat Oncol Biol Phys 34:21–26
Manimaran S (2007) Radiobiological equivalent of low/high dose rate brachytherapy and evaluation of tumor and normal responses to the dose. Radiat Med 25:229–235
Monge RM, Jurado M, Azinovic I et al (1993) Intraoperative radiotherapy in recurrent gynecological cancer. Radiother Oncol 28: 127-133
Morley GW, Lindenauer SM (1976) Pelvic exenterative therapy for gynecologic malignancy: an analysis of 70 cases. Cancer 38:581–586
Mundt AJ, Lujan AE, Rotmensch J et al (2002) Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys 52:1330–1337
Murphy WT, Schmitz A (1956) The results of re-irradiation in cancer of the cervix. Radiology 67:378–385
Nag S, Gupta N (2000) A simple method of obtaining equivalent doses for use in HDR brachytherapy. Int J Radiat Oncol Biol Phys 46:507–513
Nieder C, Milas L, Ang KK (2000) Tissue tolerance to reirradiation. Semin Radiat Oncol 10:200–209
Ooi BS, Tjandra JJ, Green MD (1999) Morbidities of adjuvant chemotherapy and radiotherapy for resectable rectal cancer: an overview. Dis Colon Rectum 42:403–418
Petignat P, Jolicoeur M, Alobaid A et al (2006) Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrence. Gynecol Oncol 101:445–449
Phillips GL, Prem KA, Adcock LL et al (1982) Vaginal recurrence of adenocarcinoma of the endometrium. Gynecol Oncol 13:323–328
Portelance L, Chao KS, Grigsby PW et al (2001) Intensity-modulated radiation therapy (IMRT) reduces small bowel, rectum, and bladder doses in patients with cervical cancer receiving pelvic and para-aortic irradiation. Int J Radiat Oncol Biol Phys 51:261–266
Potter ME, Alvarez RD, Gay FL et al (1990) Optimal therapy for pelvic recurrence after radical hysterectomy for early-stage cervical cancer. Gynecol Oncol 37:74–77
Potter R, Haie-Meder C, Van Limbergen E, et al (2006) Recommendations from gynaecological (GYN) GEC ESTRO working group (II): concepts and terms in 3D image-based treatment planning in cervix cancer brachytherapy-3D dose volume parameters and aspects of 3D image-based anatomy, radiation physics, radiobiology. Radiother Oncol 78:67–77
Potter R, Dimopoulos J, Georg P et al (2007) Clinical impact of MRI assisted dose volume adaptation and dose escalation in brachytherapy of locally advanced cervix cancer. Radiother Oncol 83:148–155
Pourquier H, Delard R, Achille E et al (1987) A quantified approach to the analysis and prevention of urinary complications in radiotherapeutic treatment of cancer of the cervix. Int J Radiat Oncol Biol Phys 13:1025–1033
Prempree T, Amornmarn R, Villasanta U et al (1984) Retreatment of very late recurrent invasive squamous cell carcinoma of the cervix with irradiation. II. Criteria for patients’ selection to achieve the success. Cancer 54:1950–1955
Randall ME, Evans LE, Greven KM et al (1993) Interstital reirradiation for recurrent gynecologic malignancies: results and analysis of prognostic factors. Gynecol Oncol 48: 23-31
Roberts WS, Cavanagh D, Bryson SC et al (1987) Major morbidity after pelvic exenteration: a seven-year experience. Obstet Gynecol 69:617–621
Russell AH, Koh WJ, Markette K et al (1987) Radical reirradiation for recurrent or second primary carcinoma of the female reproductive tract. Gynecol Oncol 27:226–232
Sharma S, Odunsi K, Driscoll D et al (2005) Pelvic exenterations for gynecological malignancies: twenty-year experience at Roswell Park Cancer Institute. Int J Gynecol Cancer 15:475–482
Sommers GM, Grigsby PW, Perez CA et al (1989) Outcome of recurrent cervical carcinoma following definitive irradiation. Gynecol Oncol 35:150–155
Stewart FA (1986) Mechanism of bladder damage and repair after treatment with radiation and cytostatic drugs. Br J Cancer Suppl 7:280–291
Stewart FA (1999) Re-treatment after full-course radiotherapy: is it a viable option? Acta Oncol 38:855–862
Stewart FA, van der Kogel AJ (1994) Retreatment tolerance of normal tissues. Semin Radiat Oncol 4:103–111
Stewart FA, Oussoren Y, Luts A (1990) Long-term recovery and reirradiation tolerance of mouse bladder. Int J Radiat Oncol Biol Phys 18:1399–1406
Thomas GM, Dembo AJ, Myhr T et al (1993) Long-term results of concurrent radiation and chemotherapy for carcinoma of the cervix recurrent after surgery. Int J Gynecol Cancer 3:193–198
Tran PT, Su Z, Hara W (2007). Long-term survivors using intraoperative radiotherapy for recurrent gynecologic malignancies. Int J Radiat Oncol Biol Phys 69: 504-511
Van de Kamer JB, De Leeuw AA, Moerland MA et al (2010) Determining DVH parameters for combined external beam and brachytherapy treatment: 3D biological dose adding for patients with cervical cancer. Radiother Oncol 94:248–253
Wang XE, Cai S, Ding Y et al (1998) Treatment of late recurrent vaginal malignancy after initial radiotherapy for carcinoma of the cervix: an analysis of 73 cases. Gynecol Oncol 69: 125-129
Xiang EW, Shu-mo C, Ya-qin D et al (1998) Treatment of late recurrent vaginal malignancy after initial radiotherapy for carcinoma of the cervix: an analysis of 73 cases. Gynecol Oncol 69:125–129
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2010 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Morgia, M., Walsh, L., Milosevic, M., Levin, W., Fyles, A. (2010). Gynaecological Malignancies. In: Nieder, C., Langendijk, J. (eds) Re-irradiation: New Frontiers. Medical Radiology(). Springer, Berlin, Heidelberg. https://doi.org/10.1007/174_2010_106
Download citation
DOI: https://doi.org/10.1007/174_2010_106
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-12467-9
Online ISBN: 978-3-642-12468-6
eBook Packages: MedicineMedicine (R0)